Neuropsychopharmacology
- Electrophysiological correlates of attention in the locus coeruleus–prelimbic cortex circuit during the rodent continuous performance test1 year ago
- Moving beyond descriptive nosology: an argument for negative valence systems disorder1 year ago
- Microbes and mental health: translating preclinical findings to the clinic1 year ago
- Repurposing anti-inflammatory medications for alcohol and substance use disorders1 year ago
- High-intensity sweet taste as a predictor of subjective alcohol responses to the ascending limb of an intravenous alcohol prime: an fMRI study1 year ago
- Digital and precision clinical trials: innovations for testing mental health medications, devices, and psychosocial treatments1 year ago
- Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward1 year ago
Journal of Psychopharmacology
- The effect of metformin on cognitive function: A systematic review and meta-analysis3 years ago
- Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning3 years ago
- Clinical validation of the Aarhus Side effect Assessment Questionnaire(ASAQ)3 years ago
- The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder3 years ago
- Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine3 years ago
- A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults3 years ago
- LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking3 years ago
European Neuropsychopharmacology
- Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?2 years ago
- Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders2 years ago
- Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan2 years ago
- The potential of TAAR1 agonists in bipolar disorder2 years ago
- The antipsychotic paradox: Lessons regarding determinants of premature mortality2 years ago
- Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors: Glutathione in COVID-192 years ago
- Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery2 years ago